US2004152103A1PendingUtilityA1
Novel methods for obtaining, identifying and applying nucleic acid sequences and (poly)peptides which increase the expression yields of periplasmic proteins in functional form
Priority: Oct 23, 1997Filed: Aug 19, 2003Published: Aug 5, 2004
Est. expiryOct 23, 2017(expired)· nominal 20-yr term from priority
C12N 15/70C07K 14/245C12N 15/1037C07K 16/00C40B 40/02C12Q 1/6811
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for obtaining nucleic acid sequences encoding (poly)peptides which increase the expression yields of periplasmic proteins in functional form upon co-expression of said (poly)peptides and said periplasmic proteins. The invention also provides a method for the identification of said (poly)peptides. Furthermore, the present invention relates to a method for increasing the expression yields of periplasmic proteins in functional form by co-expressing (poly)peptides, for example Skp, FkpA, or a homolog of Skp or FkpA, in bacteria.
Claims
exact text as granted — not AI-modified1 . A method for obtaining a nucleic acid sequence comprising a (poly)peptide coding sequence, which increases the expression yield of a periplasmic protein in functional form in bacteria upon co-expression of said periplasmic protein and said (poly)peptide, comprising the steps of:
(a) providing a collection of host cells wherein each cell contains
(i) a first nucleic acid sequence out of a collection of nucleic acid sequences, and
(ii) a second nucleic acid sequence encoding said periplasmic protein;
(b) causing or allowing expression of
(i) (poly)peptides expressible from said collection of nucleic acid sequences, and
(ii) said periplasmic protein expressible from said second nucleic acid sequence;
(c) screening or selecting for a host cell expressing said periplasmic protein with increased functional yield; (d) optionally, repeating step (c) one or more times; (e) obtaining said first nucleic acid sequence contained in said host cell.
2 . The method of claim 1 , further comprising the step of identifying a (poly)peptide coding sequence comprised in said first nucleic acid sequence.
3 . The method of claims 1 or 2 , wherein said first nucleic acid sequence is or is derived from genomic DNA or mRNA of an organism, or cDNA.
4 . The method of anyone of claims 1 to 3 , wherein said first nucleic acid sequence comprises an at least partially randomized sequence.
5 . The method of anyone of claims 1 to 4 , wherein
(a) said first nucleic acid sequence is comprised in a vector which can be packaged in a filamentous phage particle, and
(b) said periplasmic protein is a fusion protein of at least part of a filamentous phage coat protein and a further protein;
and wherein in the course of said expression a collection of filamentous phage particles displaying said further protein is produced from said collection of host cells.
6 . The method of anyone of claims 1 to 5 wherein said further protein comprises at least a domain of the immunoglobulin superfamily, and preferably of the immunoglobulin family.
7 . The method of claim 6 wherein said further protein is an immunoglobulin fragment taken from the list of Fv, scFv, disulphide-linked Fv, and Fab fragments.
8 . A method for identifying a (poly)peptide which increases the expression yield of a periplasmic protein in functional form in bacteria upon co-expression of said periplasmic protein and said (poly)peptide, comprising the steps of:
(a) identifying a nucleic acid sequence or a (poly)peptide coding sequence according to a method of anyone of claims 1 to 7 , and (b) deducing a (poly)peptide therefrom.
9 . A method for increasing the expression of a periplasmic protein in functional form in a bacterial host cell, characterized by co-expressing said periplasmic protein and a (poly)peptide identified by the method according to claim 8 .
10 . The method of claim 9 , wherein said periplasmic protein is a member of a collection of periplasmic proteins expressed in a collection of host cells.
11 . The method of claims 9 or 10 wherein said (poly)peptide is the E. coli protein Skp or a homolog thereof.
12 . The method of claims 9 or 10 wherein said (poly)peptide is the E. coli protein FkpA or a homolog thereof.
13 . The method of anyone of claims 9 to 12 wherein said periplasmic protein ia a fusion protein of at least part of a filamentous phage coat protein and a further protein.
14 . The method of anyone of claims 9 to 13 wherein said further protein comprises at least a domain of the immunoglobulin superfamily, and preferably of the immunoglobulin family.
15 . The method of claim 14 , wherein the further protein is an immunoglobulin fragment taken from the list of Fv, scFv, disulphide-linked Fv, and Fab fragment.Join the waitlist — get patent alerts
Track US2004152103A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.